These results were consistent across various transplantation routes, the Trp53 status of the murine PDA cell lines, short hairpin sequences for Kdm8 targeting, and the presence or absence of anti-tumor immune surveillance. This evidence concerns the gene KDM8 and Patent ductus arteriosus.